ClinicalTrials.gg
RecruitingNCT07869563Updated Oct 9, 2026

Ultrasound-assisted Nasal Bone Fracture Reduction

An interventional study of Ultrasound-guided nasal bone fracture reduction and No ultrasound-guided nasal bone fracture reduction in Nasal Bone Fracture and Ultrasound, sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine. Recruiting at 2 sites in China. Open to participants aged 5 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 8 months after the study started (first participant enrolled Jan 2023, registered Sep 2026).
  • Started Jan 2023; still recruiting 3 years 10 months later.
Updated Oct 9, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
5 Years to 70 Years
Sex
All
01

Study summary

Clinical Trial Abstract Nasal bone fracture is the most common traumatic disease in otorhinolaryngology, which adversely affects nasal appearance and physiological function. Traditional closed reduction relies merely on visual observation and palpation without objective intraoperative evaluation, often leading to insufficient reduction in comminuted, overlapping, or severely swollen fractures and residual nasal deformity. Musculoskeletal ultrasound features real-time dynamic imaging, radiation-free performance, and convenient operation, enabling visualized and precise fracture reduction. However, conventional ultrasound imaging for nasal bones is compromised by air interference due to the protruding nasal structure. This study aims to determine the optimal scanning parameters and suitable coupling agents for high-quality nasal bone imaging by enrolling healthy volunteers and fracture patients. Furthermore, it compares operative duration, postoperative CT scores, and physician and patient satisfaction between traditional reduction and ultrasound-assisted reduction groups. This study intends to establish a standardized intraoperative ultrasound-assisted nasal bone reduction protocol to improve reduction accuracy and clinical satisfaction.

02

Conditions studied

  • Nasal Bone Fracture
  • Ultrasound
03

In context

Lead sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine is the lead sponsor of 100 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with nasal trauma within 2 weeks, accompanied by nasal deformity or nasal ventilation dysfunction.

Exclusion criteria

Exclusion Criteria:

  • Aged over 70 years or under 5 years, combined with orbital or intracranial injury, or with surgical .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Ultrasound assist

    Ultrasound-guided nasal bone fracture reduction

    Procedure: Ultrasound-guided nasal bone fracture reduction

  • Active comparator
    No ultrasound assist

    No ultrasound assists nasal bone fracture reduction

    Procedure: No ultrasound-guided nasal bone fracture reduction

Interventions

  • ProcedureUltrasound-guided nasal bone fracture reduction

    Ultrasound-guided nasal bone fracture reduction

  • ProcedureNo ultrasound-guided nasal bone fracture reduction

    No ultrasound-guided nasal bone fracture reduction

06

What researchers measure

Primary outcomes

  1. Change in patient satisfaction with nasal appearance and function assessed by Visual Analogue Scale

    Patient satisfaction regarding nasal function and nasal cosmetic appearance measured by Visual Analogue Scale (VAS). VAS ranges from 0 (completely satisfied) to 10 (completely dissatisfied). Outcome is the change from baseline in VAS score.

    Time frame: 2 weeks and 3months after surgery

  2. Change in physician-rated nasal appearance assessed by a standardized objective nasal appearance scale

    Physician-rated nasal cosmetic appearance assessed by two independent, blinded otolaryngologists using the standardized objective nasal appearance scale. The scale evaluates nasal dorsal alignment, dorsal contour, tip position, nasal symmetry, and overall deformity; each item scores from 0 to 3, total score ranges from 0 to 15, with higher scores indicating greater aesthetic impairment. The outcome is the change from baseline in the total objective appearance score.

    Time frame: 2 weeks and 3months after surgery

07

Study locations

1 of 2 sites recruiting
  • The Second Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang 310009, China
    Active, not recruiting

    Not enrolling at this site.

  • The Second Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang 3100, China
    Recruiting
    • Hong-gang Duan · Contact
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2023 (actual). Primary completion is estimated for Sep 2029, 80 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Oct 9, 2026
StartActual
Jan 1, 2023
Primary completionEst.
Sep 1, 2029
CompletionEst.
Sep 1, 2029
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07869563
Responsible party
Sponsor
First posted
Oct 9, 2026
Start date
Jan 1, 2023
Primary completion
Sep 1, 2029 (estimated)
Completion
Sep 1, 2029 (estimated)
Last update
Oct 9, 2026

Study contacts

Hong-gang Duan, doctor
Contact
2314061@zju.edu.cn
13429124832

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion